Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Medicare to negotiate prices for top drugs
Medicare announced plans to negotiate lower prices for 15 costly drugs, including Ozempic, Wegovy, and Trelegy Ellipta, starting in 2027. These medications, used for conditions like diabetes, weight loss, and asthma, accounted for $41 billion in Medicare spending last year. Novo Nordisk’s drugs alone cost $14.4 billion.
USA TODAY on MSN13d
Medicare caps seniors drug expenses: What you need to knowMedicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs. The cap ...
Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be ...
The median wait time between referral and appointment was 34 days, and 18 percent of patients waited more than 90 days, the ...
Medicare premiums and deductibles have increased for all retirees. There's now a $2,000 cap on annual out-of-pocket ...
The baby boomer generation is undoubtedly the most important demographic for most investors to consider, from a sheer size ...
Across America, companies that provide vital medical equipment to Medicare patients in their homes are drastically cutting services -- or shutting their doors completely. Without action, millions of ...
Part C is a bundled plan that you would call Medicare Advantage. It is an opportunity that you have to choose what kind of Medicare program you want. You can pick your doctor as long as he or she is a ...
Black Hills Chamber Music Society presents Erinys Quartet, 7 p.m., The Journey Museum theater, Rapid City. In residence at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback